D.E. Shaw & Co
HALO icon

D.E. Shaw & Co’s Halozyme HALO Stock Holding History

D.E. Shaw & Co’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.21M Buy
28,200
+7,300
+35% +$498K ﹤0.01% 3117
2026
Q1 		$1.35M Buy
+20,900
New +$1.47M ﹤0.01% 3205
2015
Q2 		– Sell
-53,000
Closed -$757K – 3783
2015
Q1 		$757K Buy
+53,000
New +$764K ﹤0.01% 2766

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

D.E. Shaw & Co's HALO Position: Q2 2026 in Review

D.E. Shaw & Co increased its Halozyme (HALO) stake by 7.4% in Q2 2026, buying an estimated $9.39M and bringing the position to 2,006,479 shares worth $157M. The position accounts for 0.07% of the portfolio, ranked #278.

D.E. Shaw & Co first reported a position in HALO in Q1 2014 and has held it in 47 quarters since. The position peaked at $194M in Q3 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • D.E. Shaw & Co held 2,006,479 shares of Halozyme worth $157M as of Q2 2026.
  • D.E. Shaw & Co bought 137,771 Halozyme shares in Q2 2026, an estimated $9.39M.
  • Halozyme made up 0.07% of D.E. Shaw & Co's portfolio in Q2 2026, its #278 holding.
  • D.E. Shaw & Co first reported a position in Halozyme in Q1 2014 and has held it in 47 quarters since.
  • D.E. Shaw & Co's Halozyme position peaked at $194M in Q3 2025.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.